• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Characterization of Vibrio cholerae eltor in the city of Kazan in 2001].

作者信息

Onishchenko G G, Lomov Iu M, Mishan'kin B N, Mazrukho B L, Podosinnikova L S, Kudriakova T A, Moskvitina E A, Vodop'ianov S O, Ryzhko I V, Kazakova E S, Sharova I N, Plotnikova E A, Davydova N A, Abramova E G, Korolev Iu S, Shestialtynova I S, Sharifulina D M, Kuriaeva N Iu, Iumangulova E F, Chernyshova A V, Bugorkova T V, Rusakova T G, Maslenikova A L, Milova M V, Zakharova L I, Bilalova T G, Shut'ko A G, Kachkina G V

机构信息

Ministry of Health, Russian Federation, Moscow.

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 2002 Mar-Apr(2):3-6.

PMID:12043149
Abstract

Information on V. cholerae eltor isolated in the focus of cholera in Kazan in 2001 at different periods of the outbreak is presented. The identity of strains isolated from patients, vibriocarriers and environmental objects, including their antibioticograms (sensitivity to cyprofloxacin and resistance to trimethoprim--sulfamethoxazole, streptomycin, furazolidone and nalidixic acid, which may be regarded as markers), is shown. Variable tandem repetitions in the DNA of 30 isolates strains of different origin have been determined. The results of this determination make it possible to classify all these strains as one genotype, which confirms the suggestion on the circulation of one subclone of the infective agent of cholera in the focus. As revealed in this investigation, the isolated strains are labile with respect to diagnostic phage eltor, while ctx+ strains are resistant to phage eltor ctx+.

摘要

相似文献

1
[Characterization of Vibrio cholerae eltor in the city of Kazan in 2001].
Zh Mikrobiol Epidemiol Immunobiol. 2002 Mar-Apr(2):3-6.
2
[Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].[霍乱弧菌埃尔托生物型对萘啶酸和氟喹诺酮类药物的实验性耐药性]
Antibiot Khimioter. 2000;45(9):7-12.
3
[Antibiotic sensitivity of Vibrio cholerae 01, isolated in the Ukraine in 1994].[1994年在乌克兰分离出的霍乱弧菌01型的抗生素敏感性]
Antibiot Khimioter. 1996 Jun;41(6):25-8.
4
Molecular Epidemiology and Antibiotic Susceptibility of Vibrio cholerae Associated with a Large Cholera Outbreak in Ghana in 2014.2014年加纳大规模霍乱疫情相关霍乱弧菌的分子流行病学及抗生素敏感性研究
PLoS Negl Trop Dis. 2016 May 27;10(5):e0004751. doi: 10.1371/journal.pntd.0004751. eCollection 2016 May.
5
[Genetic characterization of Vibrio cholerae strains emerging in Russian Federation during 7th cholera pandemic].[俄罗斯联邦在第七次霍乱大流行期间出现的霍乱弧菌菌株的基因特征分析]
Zh Mikrobiol Epidemiol Immunobiol. 2011 May-Jun(3):3-10.
6
[Antibacterial susceptibility/resistance of Vibrio cholerae eltor clinical strains isolated in the Caucasus during the seventh cholera pandemic].[第七次霍乱大流行期间在高加索地区分离出的埃尔托霍乱弧菌临床菌株的抗菌药敏性/耐药性]
Antibiot Khimioter. 2010;55(5-6):8-13.
7
[Antibioticograms of Vibrio cholerae non-01/non-0139 strains isolated from humans within 1968-2009].[1968年至2009年间从人类分离出的非01/非0139型霍乱弧菌的抗生素敏感性图谱]
Antibiot Khimioter. 2011;56(1-2):18-21.
8
Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta.1989 - 1990年加尔各答连续两个霍乱季节分离出的霍乱弧菌的血清型、生物型、噬菌体类型、产毒性及抗生素敏感性模式。
Indian J Med Res. 1992 May;95:125-9.
9
[Characterization of Vibrio cholerae cultures isolated in foci of cholera in the city of Kazan].[喀山市霍乱疫源地分离出的霍乱弧菌培养物的特性研究]
Zh Mikrobiol Epidemiol Immunobiol. 2002 Nov-Dec(6):78-80.
10
High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.2008年6月至9月期间,伊朗德黑兰霍乱疫情中霍乱弧菌多重耐药菌株的高流行率。
Trop Doct. 2010 Oct;40(4):214-6. doi: 10.1258/td.2010.100015. Epub 2010 Aug 13.